Supportive Care in Cancer

, Volume 13, Issue 5, pp 332–338 | Cite as

Patients with haematological malignancies requiring invasive mechanical ventilation: differences between survivors and non-survivors in intensive care unit

  • Radoslaw Owczuk
  • Magdalena A. Wujtewicz
  • Wioletta Sawicka
  • Anna Wadrzyk
  • Maria Wujtewicz
Original Article



Mortality of patients with haematological malignancies requiring intensive therapy is high. We wanted to establish reasons for intensive care unit (ICU) admission and treatment as well as outcome in subjects who required invasive mechanical ventilation. We were also interested in differences between ICU survivors and non-survivors at the moment of admission.

Patients and methods

Forty patients (21 women and 19 men) were included in the study. Median of age was 42 (range 16–73) years. All patients required mechanical ventilation. We analysed age, gender, disease character (acute/chronic), diagnosed pneumonia, multiple organ failure (MOF), history of bone marrow transplantation, peripheral blood parameters (leukocyte, neutrocyte, erythrocyte and thrombocyte counts, haemoglobin level and haematocrit), mean arterial pressure (obtained through direct measurement), necessity of catecholamine administration and symptoms of the acute renal insufficiency at the moment of ICU admission.

Main results

Sixty-five percent of patients died in ICU. Intergroup comparisons between survivors and non-survivors revealed statistically significant differences in the presence of neutropenia, thrombocyte count, mean arterial pressure and the necessity of catecholamines administration, as well as scores obtained through patient evaluation according to the Acute Physiology and Chronic Health Evaluation (APACHE II), the Sequential Organ Failure Assessment (SOFA) and the New Simplified Acute Physiology Score (SAPS II) scales. Multivariate logistic regression revealed only one independent risk factor for ICU mortality in the analysed group—SAPS II score (p=0.009). Calculated value of the unitary odds ratio was 1.065 (95% confidence interval 1.017–1.116).


Mortality of patients with haematological malignancies requiring intensive mechanical ventilation remains high. Scoring with the SAPS II system was a useful tool for determination of ICU mortality risk in those patients.


Haematological malignancies Intensive care Mechanical ventilation Respiratory insufficiency Prognostic factors 


  1. 1.
    Ashkenazi YJ, Kramer BS, Harman E (1986) Short-term outcome among patients with leukemia and lymphoma admitted to a medical intensive care unit. South Med J 79:1086–1088PubMedGoogle Scholar
  2. 2.
    Azoulay E, Fieux F, Moreau D, Thiery G, Rousselot P, Parrot A, Le Gall J-R, Dombret H, Schlemmer B (2003) Acute monocytic leukemia presenting as acute respiratory failure. Am J Respir Crit Care Med 167:1329–1333PubMedGoogle Scholar
  3. 3.
    Azoulay E, Recher C, Alberti C, Soufir L, Leleu G, Le Gall JR, Fermand JP, Schlemmer B (1999) Changing use of intensive care for hematological patients: the example of multiple myeloma. Intensive Care Med 25:1395–1401PubMedGoogle Scholar
  4. 4.
    Benoit DD, Vandewoude KH, Decruyenaere JM, Hoste EA, Colardyn FA (2003) Outcome and early prognostic indicators in patients with a hematologic malignancy admitted to the intensive care unit for a life-threatening complications. Crit Care Med 31:104–112CrossRefPubMedGoogle Scholar
  5. 5.
    Blot F, Guiguet M, Nitenberg G, Leclercq B, Gachot B, Escudier B (1997) Prognostic factors for neutropenic patients in an intensive care unit: respective roles of underlying malignancies and acute organ failures. Eur J Cancer 33:1031–1037CrossRefPubMedGoogle Scholar
  6. 6.
    Brunet F, Lanore JJ, Dhainaut JF, Drefus F, Vaxelaire J, Nouira S, Giraud T, Armaganidis A, Monsallier JF (1990): Is intensive care justified for patients with hematological malignancies? Intensive Care Med 16:291–297PubMedGoogle Scholar
  7. 7.
    Conti G, Marino P, Cogliati A, Dell’Utri D, Lappa A, Rosa G, Gasparetto A (1998) Noninvasive ventilation for the treatment of acute respiratory failure in patients with hematologic malignancies: a pilot study. Intensive Care Med 24:1283–1288PubMedGoogle Scholar
  8. 8.
    Epner DE, White P, Krasnoff M, Khanduja S, Kimball KT, Knaus WA (1996) Outcome of mechanical ventilation for adults with hematologic malignancy J Investig Med 44:254–260Google Scholar
  9. 9.
    Estopa R, Torres Marti A, Kastanos N, Rives A, Agusti-Vidal A, Rozman C (1984) Acute respiratory failure in severe hematologic disorders. Crit Care Med 12:26–28PubMedGoogle Scholar
  10. 10.
    Evison JM, Rickenbacher P, Ritz R, Gratwohl A, Haberthűr Ch, Elsasser S, Passweg JR (2001) Intensive care unit admission in patients with haematological disease: incidence, outcome and prognostic factors. Swiss Med Wkly 131:681–686PubMedGoogle Scholar
  11. 11.
    Ewig S, Torres A, Riquelme R, El-Ebiary M, Rovira M, Carreras E, Rano A, Xaubet A (1998) Pulmonary complications in patients with haematological malignancies treated at a respiratory ICU. Eur Respir J 12:116–122CrossRefPubMedGoogle Scholar
  12. 12.
    Huaringa AJ, Leyva FJ, Giralt SA, Blanco J, Signes-Costa J, Velarde H, Champlin RE (2000) Outcome of bone marrow transplantation patients requiring mechanical ventilation. Crit Care Med 28:1014–1017PubMedGoogle Scholar
  13. 13.
    Johnson MH, Gordon PW, Fitzgerald FT (1986) Stratification of prognosis in granulocytopenic patients with hematologic malignancies using the APACHE-II severity of illness score. Crit Care Med 14:693–697PubMedGoogle Scholar
  14. 14.
    Knaus WA, Draper EA, Wagner DP, Zimmerman JE (1985) Apache II: a severity of disease classification system. Crit Care Med 13:818–829PubMedGoogle Scholar
  15. 15.
    Knaus WA, Draper EA, Wagner DP, Zimmerman JE (1985) Prognosis in acute organ-system failure. Ann Surg 11:685–693Google Scholar
  16. 16.
    Kongsgaard UE, Meidell NK (1999) Mechanical ventilation in critically ill cancer patients: outcome and utilisation of resources. Support Care Cancer 7:95–99PubMedGoogle Scholar
  17. 17.
    Kress JP, Christenson J, Pohlman AS, Linkin DR, Hall JB (1999) Outcomes of critically ill cancer patients in a university hospital setting. Am J Respir Crit Care Med. 160: 1957–1961Google Scholar
  18. 18.
    Kroschinsky F, Weise M, Illmer T, Haenel M, Bornhaeuser M, Hoeffken G, Ehninger G, Schuler U (2002) Outcome and prognostic features of intensive care unit treatment in patients with hematological malignancies. Intensive Care Med 28:1294–1300CrossRefPubMedGoogle Scholar
  19. 19.
    Le Gall JR, Lemeshow S, Saulnier F (1993) A new simplified acute physiology score (SAPS II) based on a European/North American multicentre study. JAMA 270:2957–2963PubMedGoogle Scholar
  20. 20.
    Lloyd-Thomas AR, Dhaliwal HS, Lister TA, Hinds CJ (1986) Intensive therapy for life-threatening medical complications of haematological malignancy. Intensive Care Med. 12:317–324Google Scholar
  21. 21.
    Lloyd-Thomas AR, Wright I, Lister TA, Hinds CJ (1988) Prognosis of patients receiving intensive care for life threatening medical complications of haematological malignancy. Br Med J 296:1025–1029Google Scholar
  22. 22.
    Massion PB, Dive AM, Doyen C, Bulpa P, Bosly A, Installe E (2002) Prognosis of hematologic malignancies does not predict intensive care unit mortality. Crit Care Med 30:2260–2270CrossRefPubMedGoogle Scholar
  23. 23.
    Meert AP, Close L, Hardy M, Berghmans T, Markiewicz E, Sculier JP (2003) Noninvasive ventilation: application to the cancer patient admitted in the intensive care unit. Support Care Cancer 11:56–59PubMedGoogle Scholar
  24. 24.
    Peters S, Meadows JA, Gracey D (1988) Outcome of respiratory failure in hematologic malignancy. Chest 94:99–102PubMedGoogle Scholar
  25. 25.
    Poletti V, Trisolini R, Tura S (2002) Pulmonary disease in patients with hematologic malignancies. Sarcoidosis Vasc Diffuse Lung Dis 191:29–45Google Scholar
  26. 26.
    Rabe C, Mey U, Paashaus M, Musch A, Tasci S, Glasmacher A, Schmidt-Wolf IG, Sauerbruch T, Dumoulin FL (2004) Outcome of patients with acute myeloid leukemia and pulmonary infiltrates requiring invasive mechanical ventilation-a retrospective analysis. J Crit Care 19:29–35PubMedGoogle Scholar
  27. 27.
    Schuster D, Marion J (1983) Precedents for meaningful recovery during treatment in a medical intensive care unit: outcome in patients with hematologic malignancy. Am J Med 75:402–308CrossRefPubMedGoogle Scholar
  28. 28.
    Shorr AF, Moores LK, Edenfield WJ, Christie RJ, Fitzpatrick TM (1999) Mechanical ventilation in hematopoietic stem cell transplantation. Chest 116:1012–1018PubMedGoogle Scholar
  29. 29.
    Silfvast T, Pettilä V, Ihalainen A, Elonen E (2003) Multiple organ failure and outcome of critically ill patients with haematological malignancy. Acta Anaesthesiol Scand 47:301–306PubMedGoogle Scholar
  30. 30.
    Trebmlay LN, Hyland RH, Schouten BD, Hanly PJ (1995) Survival of acute myelogenous leukemia patients requiring intubation/ventilatory support. Clin Invest Med 18:19–24PubMedGoogle Scholar
  31. 31.
    Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, Reinhart CK, Suter PM, Thijs LG (1996) The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Med 22:707–710CrossRefPubMedGoogle Scholar
  32. 32.
    Wedding U, Bokemeyer C, Meran JG (2004) Elderly patients with acute myeloid leukaemia: characteristics in biology, patients and treatment. Recommendations of the Working Group Geriatric Oncology of the German Society for Haematology and Oncology (DGHO), the Austrian Society for Haematology and Oncology (OGHO) and the German Society for Geriatrics (DGG). Onkologie 27:72–82PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2004

Authors and Affiliations

  • Radoslaw Owczuk
    • 1
  • Magdalena A. Wujtewicz
    • 1
  • Wioletta Sawicka
    • 1
  • Anna Wadrzyk
    • 1
  • Maria Wujtewicz
    • 1
  1. 1.Department of Anaesthesiology and Intensive TherapyMedical University of GdanskGdanskPoland

Personalised recommendations